Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 5, p. 407, doi. 10.1038/sj.cgt.7700449
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2002 AND VI 9 AND IP 5
Results: 9
1
2
Application of interleukin-2–secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 5, p. 464, doi. 10.1038/sj.cgt.7700459
- By:
- Publication type:
- Article
3
Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 5, p. 414, doi. 10.1038/sj.cgt.7700455
- By:
- Publication type:
- Article
4
The murine whey acidic protein promoter directs expression to human mammary tumors after retroviral transduction.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 5, p. 421
- By:
- Publication type:
- Article
5
Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 5, p. 432, doi. 10.1038/sj.cgt.7700457
- By:
- Publication type:
- Article
6
C-terminal deletion mutant p21<sup>WAF1/CIP1</sup> enhances E2F-1–mediated apoptosis in colon adenocarcinoma cells.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 5, p. 453, doi. 10.1038/sj.cgt.7700458
- By:
- Publication type:
- Article
7
Transcription-targeted gene therapy for androgen-independent prostate cancer.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 5, p. 443, doi. 10.1038/sj.cgt.7700451
- By:
- Publication type:
- Article
8
Tumor gene therapy by MVA-mediated expression of T-cell–stimulating antibodies.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 5, p. 470, doi. 10.1038/sj.cgt.7700461
- By:
- Publication type:
- Article
9
Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 5, p. 478, doi. 10.1038/sj.cgt.7700462
- By:
- Publication type:
- Article